Literature DB >> 2529338

Echocardiographic study of U wave inversion in the electrocardiograms of hypertensive patients.

N Twidale1, A W Gallagher, A M Tonkin.   

Abstract

The prevalence of U wave inversion was evaluated in 58 adult patients with hypertension, and a possible mechanism for it was examined using M-mode echocardiographic indices. U wave inversion was the most common electrocardiographic abnormality, occurring in 34% of patients; voltage criteria for left ventricular hypertrophy were present in only 14% of patients, and ventricular strain pattern was not detected in any patient. Nonetheless, on echocardiography left ventricular posterior wall thickness was increased in 58% of patients. However, neither U wave inversion nor conventional voltage criteria for left ventricular hypertrophy was strongly predictive for this finding. The authors conclude that U wave inversion is a frequent finding in patients with hypertension, often occurring alone. Although it does not appear to be closely linked to the presence of left ventricular hypertrophy, it may relate to other, perhaps subtle, abnormalities of diastolic ventricular relaxation.

Entities:  

Mesh:

Year:  1989        PMID: 2529338     DOI: 10.1016/0022-0736(89)90013-7

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  3 in total

1.  U wave variability in the surface ECG.

Authors:  Piotr Kukla; Adrian Baranchuk; Marek Jastrzębski; Leszek Bryniarski
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-21       Impact factor: 1.468

Review 2.  The negative U wave: a pathogenetic enigma but a useful, often overlooked bedside diagnostic and prognostic clue in ischemic heart disease.

Authors:  Ernesto Correale; Rossano Battista; Vincenzo Ricciardiello; Angelina Martone
Journal:  Clin Cardiol       Date:  2004-12       Impact factor: 2.882

3.  Electrocardiographic T- and U-wave discordance.

Authors:  Michael G Reinig; Robert Harizi; David H Spodick
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-01       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.